This data suggests that secondary dengue patient samples with high neutralizing antibody titres showed no to low infection-enhancing activity in Vero-CD32a cells, confirming the lack of utility of this test in detecting ADE. The gene discussed is FCGR2A; the disease is acute disseminated encephalomyelitis.